menu
    • menu

    Company profile for Structure Therapeutics

    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Structure Therapeutics is a clinical-stage global biopharmaceutical company discovering and developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Structure Therapeutics’ pipeline includes two clinical-stage compounds that have been designed from the company’s technology platform. By leveraging Structure Therapeutics’ world-class structure-based drug discovery know-how, the...
    Structure Therapeutics is a clinical-stage global biopharmaceutical company discovering and developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Structure Therapeutics’ pipeline includes two clinical-stage compounds that have been designed from the company’s technology platform. By leveraging Structure Therapeutics’ world-class structure-based drug discovery know-how, the company aims to design differentiated small molecule therapies to overcome the limitations of biologics and peptide therapies, starting with a focus on the GPCR cell surface family of drug targets.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Structure TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    701 Gateway Blvd. Suite 410 South San Francisco, CA 94080
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://structuretx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/structuretx/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/ShouTiPharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Roche Commits $100M To Keep Its GLP-1 Structure Sound
    Roche Commits $100M To Keep Its GLP-1 Structure Sound

    06 Jan 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/roche-shores-100m-keep-its-glp-1-structure-sound

    FIERCE BIOTECH
    06 Jan 2026
    Share Share
    Structure Therapeutics Initiates Phase 1 Study Of Oral ACCG-2671
    Structure Therapeutics Initiates Phase 1 Study Of Oral ACCG-2671

    17 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/17/3206968/0/en/Structure-Therapeutics-Announces-Initiation-of-Phase-1-Clinical-Study-of-Oral-Small-Molecule-Amylin-Receptor-Agonist-ACCG-2671-for-the-Treatment-of-Obesity.html

    GLOBENEWSWIRE
    17 Dec 2025
    Share Share
    Structure Announces Closing of Upsized $747.5 M Public Offering
    Structure Announces Closing of Upsized $747.5 M Public Offering

    11 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/11/3204285/0/en/Structure-Therapeutics-Announces-Closing-of-Upsized-747-5-Million-Public-Offering-of-ADSs-and-Pre-Funded-Warrants-and-Full-Exercise-of-the-Underwriters-Option-to-Purchase-Additiona.html

    GLOBENEWSWIRE
    11 Dec 2025
    Share Share
    Structure Plans $500M Public Offering of America Depository
    Structure Plans $500M Public Offering of America Depository

    08 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/08/3201959/0/en/Structure-Therapeutics-Announces-Proposed-500-Million-Public-Offering-of-American-Depositary-Shares-and-Pre-Funded-Warrants.html

    GLOBENEWSWIRE
    08 Dec 2025
    Share Share
    Wave, Structure stocks double on obesity data readouts
    Wave, Structure stocks double on obesity data readouts

    08 Dec 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/wave-structure-move-assets-clinical-ladder-biotechs-obesity-development-blitz-rolls

    FIERCE BIOTECH
    08 Dec 2025
    Share Share
    Structure Therapeutics: Positive Aleniglipron Data
    Structure Therapeutics: Positive Aleniglipron Data

    08 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/08/3201469/0/en/Structure-Therapeutics-Reports-Positive-Topline-Data-from-ACCESS-Program-for-its-Once-Daily-Oral-Small-Molecule-GLP-1-Receptor-Agonist-Aleniglipron.html

    GLOBENEWSWIRE
    08 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search